## Clinical Diagnosis: Warfarin-Induced Skin Necrosis ### Pathophysiology: The Protein C Paradox **Key Point:** Warfarin-induced skin necrosis occurs due to a transient **hypercoagulable state** caused by selective early depletion of protein C before depletion of factors II, VII, IX, and X. ### Timeline of Vitamin K-Dependent Factor Depletion | Factor | Half-life | Depletion Order | |--------|-----------|------------------| | Protein C | 8 hours | **1st (fastest)** | | Protein S | 30 hours | 2nd | | Factor VII | 6 hours | 3rd | | Factor II, IX, X | 24–72 hours | 4th–6th (slowest) | **High-Yield:** Protein C is depleted **first** because it has the shortest half-life (8 hours). During this window, factors II, IX, and X are still present, creating a transient prothrombotic state. ### Mechanism of Thrombosis ```mermaid flowchart TD A[Warfarin initiated]:::action --> B[Inhibits vitamin K-dependent factors]:::action B --> C[Protein C depleted first<br/>Half-life 8 hours]:::outcome C --> D{Anticoagulant activity lost}:::decision D -->|But procoagulants still present| E[Factors II, IX, X remain<br/>Half-life 24-72 hours]:::outcome E --> F[Transient hypercoagulability]:::urgent F --> G[Microvascular thrombosis<br/>Skin necrosis]:::urgent H[Days 3-5] --> I[Procoagulants depleted<br/>Anticoagulant restored]:::action I --> J[Hypercoagulable state resolves]:::outcome ``` **Clinical Pearl:** Warfarin-induced skin necrosis typically occurs **48–72 hours** after warfarin initiation, during the window when protein C is depleted but procoagulants remain. This matches the patient's presentation. ### Risk Factors for Warfarin-Induced Skin Necrosis 1. **Protein C deficiency** (inherited or acquired) — most important risk factor 2. **High initial warfarin dose** without bridging anticoagulation 3. **Antithrombin III deficiency** 4. **Factor V Leiden** or other thrombophilia 5. **Acute thrombotic event** (like this patient's recent DVT) **Mnemonic: PACTS — Protein C deficiency, Antithrombin deficiency, Clotting factor deficiency (inherited), Thrombophilia, Sudden warfarin initiation without bridge** ### Why This Is NOT DIC DIC would show: - Severe thrombocytopenia (this patient has 280,000/μL — normal) - Markedly prolonged PT and aPTT (this patient's aPTT is only mildly prolonged) - Severely low fibrinogen (<100 mg/dL; this patient has 180 mg/dL) - Schistocytes on blood smear This patient's labs show selective depletion of anticoagulant factors, not consumption of all coagulation factors. ### Why This Is NOT HIT HIT (heparin-induced thrombocytopenia): - Requires prior heparin exposure (patient is on warfarin) - Presents with thrombocytopenia (<100,000/μL; this patient has 280,000/μL) - Occurs 5–10 days after heparin exposure (patient's symptoms began 48 hours after warfarin) ### Why This Is NOT Antithrombin III Deficiency Antithrombin III deficiency causes thrombosis but: - Would not be acutely triggered by warfarin initiation - Would present with recurrent thrombosis, not acute skin necrosis - Would not show the characteristic timing (48–72 hours post-warfarin) ### Prevention and Management 1. **Bridging anticoagulation:** Always initiate heparin (UFH or LMWH) **before** warfarin to prevent protein C depletion paradox. 2. **Slow warfarin loading:** Use lower initial doses (5 mg) rather than high doses (10 mg). 3. **Protein C concentrate:** If skin necrosis develops, consider fresh frozen plasma or protein C concentrate. 4. **Continue heparin:** Until INR is therapeutic for 24–48 hours. **High-Yield:** The **gold standard** prevention is bridging with heparin — heparin inhibits thrombin directly and prevents thrombosis during the protein C depletion window. [cite:Harrison 21e Ch 140; Robbins 10e Ch 14] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.